The UK has an incredible opportunity to improve patients’ lives through cannabis-based medicines for some of the most debilitating conditions, such as chronic pain. Celadon Pharmaceuticals Plc is at the forefront of building this new pharmaceutical sector. We have a simple approach: high-quality UK cultivation and API manufacturing, clinical trials, and R&D into cannabinoids. We …
For those leading the company, this has been a very personal mission to produce a high-quality trial for cannabis-based medicines. James Short (CEO and co-founder of Celadon Pharmaceuticals Plc) saw his sister’s experience of living with multiple sclerosis for years and also witnessed first-hand the potential benefits of cannabis-based medicines for her condition. James also …
Read the Express news article full story There has been a new article published in the Express newspaper today about how one of Celadon’s subsidiary companies LVL Health‘s game-changing trial is providing the best data set to date in the UK for the use of cannabis-based medicines for chronic pain. Celadon Pharmaceuticals Plc is the …
There has been an excellent article published in The Times today about the groundbreaking 5,000 patient trial by one of our subsidiary companies LVL Health Medical Cannabis Clinic to study the use of medicinal cannabis to treat chronic pain. Celadon Pharmaceuticals Plc is getting ready to become the provider of medical-grade cannabis for the trial …
Input your search keywords and press Enter.